Chromocell Therapeutics (CHRO) Institutional Ownership $0.64 -0.01 (-1.45%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Chromocell Therapeutics (NYSE:CHRO)CurrentInstitutional OwnershipPercentage77.96%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$659.95KNumber ofInstitutional Sellers(last 12 months)0 Get CHRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Chromocell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Chromocell Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2024 Anson Funds Management LP251,888$660K0.0%N/A4.284% (Data available from 1/1/2016 forward) CHRO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CHRO shares? During the previous two years, the following institutional investors and hedge funds held shares of Chromocell Therapeutics shares: Anson Funds Management LP ($660K).Learn more on CHRO's institutional investors. What percentage of Chromocell Therapeutics stock is owned by institutional investors? 77.96% of Chromocell Therapeutics stock is owned by institutional investors. Learn more on CHRO's institutional investor holdings. Which institutional investors have been buying Chromocell Therapeutics stock? The following institutional investors have purchased Chromocell Therapeutics stock in the last 24 months: Anson Funds Management LP ($251.89K). How much institutional buying is happening at Chromocell Therapeutics? Institutional investors have bought a total of 251,888 shares in the last 24 months. This purchase volume represents approximately $659.95K in transactions. Related Companies NRx Pharmaceuticals Institutional Ownership Cara Therapeutics Institutional Ownership Acurx Pharmaceuticals Institutional Ownership AIM ImmunoTech Institutional Ownership TherapeuticsMD Institutional Ownership HCW Biologics Institutional Ownership Marinus Pharmaceuticals Institutional Ownership PharmaCyte Biotech Institutional Ownership Aspira Women's Health Institutional Ownership Sol-Gel Technologies Institutional Ownership This page (NYSE:CHRO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chromocell Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chromocell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CHRO Stock Alerts